Page last updated: 2024-12-07

7-amino-4-methylcoumarin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

7-Amino-4-methylcoumarin is a fluorescent compound that has been widely studied for its potential applications in various fields, including analytical chemistry, bioimaging, and drug discovery. It exhibits strong fluorescence in the blue region of the visible spectrum, making it suitable for fluorescence microscopy and other applications. The compound is typically synthesized through a multi-step process involving the condensation of 4-methylresorcinol with an appropriate aromatic amine derivative. 7-Amino-4-methylcoumarin has been shown to possess antimicrobial activity against a range of bacterial and fungal species, potentially due to its ability to disrupt cellular processes. Moreover, its fluorescence properties have been utilized to develop fluorescent probes for the detection of various analytes, including metal ions, enzymes, and biomolecules. The compound has also been investigated as a potential drug candidate for the treatment of certain diseases, including Alzheimer's disease and cancer. Its ability to modulate biological processes and its strong fluorescence make it a valuable tool in scientific research and potential therapeutic development.'

7-amino-4-methylcoumarin: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92249
CHEMBL ID270672
CHEBI ID51771
SCHEMBL ID37677
MeSH IDM0092207

Synonyms (78)

Synonym
MCM ,
nsc-45796
nsc45796
coumarin, 7-amino-4-methyl-
2h-1-benzopyran-2-one, 7-amino-4-methyl-
4-methyl-7-aminocoumarin
coumarin 120
SDCCGMLS-0028516.P002
smr000067752
MLS000057660 ,
c10h9no2
7-amino-4-methyl-chromen-2-one
7-amino-4-methyl-2h-chromen-2-one
EU-0033321
C01386
26093-31-2
7-amino-4-methylcoumarin
nh2mec
AMC ,
7-amino-4-methylcoumarin, chromophore for substrates
STK290900
MOLMAP_000069
MAYBRIDGE1_002279
OPREA1_663585
einecs 247-454-8
nsc 45796
ccris 4961
A-6591
CHEBI:51771 ,
7-amino-4-methylcoumarin, 99%
AKOS000308736
DB08168
HMS547P13
CHEMBL270672
M0760
7-amino-4-methylchromen-2-one
HMS2343I18
ocy3jct44x ,
unii-ocy3jct44x
coumarin 440
7-amc
c 120
7-amino-4-methyl-2h-1-benzopyran-2-one
(4-methyl-2-oxo-2h-chromen-7-yl)amine
FT-0621347
FT-0621348
SCHEMBL37677
7-amino-4-methylcoumarine
7-amino-4-methyl coumarin
4-methyl-7-amino-coumarin
7-amino-4-methyl-coumarin
7-amino-4-methycoumarin
PS-6205
7-amino-4-methyl-2h-chromen-2-one #
J-100007
cid_92249
7-amino-4-methyl-1-benzopyran-2-one
7-azanyl-4-methyl-chromen-2-one
bdbm71742
HB0694
AC-23087
HMS3604G16
mfcd00006868
CS-W008774
SR-01000597170-1
sr-01000597170
SY009093
2431_7-amino-4-methylcoumarin
c47m2
7-amino-4-methylcoumarin - cas 26093-31-2
7-amino-4-methylcoumarin 98%
HY-D0027
Q27097396
AM9859
DTXSID40885333
coumarin 120; amc
EN300-05587
Z57024337
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
7-aminocoumarinsAny member of the class of coumarins that contains a 7-amino-2H-chromen-2-one skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (26)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency5.55280.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency5.55280.025120.237639.8107AID886; AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency0.70790.177814.390939.8107AID2147
Chain A, Ferritin light chainEquus caballus (horse)Potency31.62285.623417.292931.6228AID485281
Chain A, CruzipainTrypanosoma cruziPotency19.73120.002014.677939.8107AID1476; AID1478
glp-1 receptor, partialHomo sapiens (human)Potency31.62280.01846.806014.1254AID624417
thioredoxin reductaseRattus norvegicus (Norway rat)Potency51.45320.100020.879379.4328AID588453; AID588456
ATAD5 protein, partialHomo sapiens (human)Potency29.09290.004110.890331.5287AID504466
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency11.22020.011212.4002100.0000AID1030
glucocerebrosidaseHomo sapiens (human)Potency31.62280.01268.156944.6684AID2101
alpha-galactosidaseHomo sapiens (human)Potency37.64604.466818.391635.4813AID1467; AID2107
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency35.48130.036619.637650.1187AID1466; AID2112; AID2242
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency25.11890.001815.663839.8107AID894
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency84.92140.425612.059128.1838AID504891
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency112.20200.050127.073689.1251AID588590
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency22.38720.00419.962528.1838AID2675
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency35.48130.251215.843239.8107AID504327
caspase-1 isoform alpha precursorHomo sapiens (human)Potency25.11890.000311.448431.6228AID900
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency35.48133.548118.039535.4813AID1466
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)Potency35.48133.548118.039535.4813AID1466
Caspase-7Homo sapiens (human)Potency25.11893.981118.585631.6228AID889
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 12Homo sapiens (human)Ki9.13000.00021.10439.9000AID650665
Carbonic anhydrase 1Homo sapiens (human)Ki5.56000.00001.372610.0000AID650662
Carbonic anhydrase 2Homo sapiens (human)Ki200.00000.00000.72369.9200AID650663
Carbonic anhydrase 9Homo sapiens (human)Ki7.64000.00010.78749.9000AID650664
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Hsf1 proteinMus musculus (house mouse)EC50 (µMol)260.00000.160024.4900236.5000AID435004
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Hsf1 proteinMus musculus (house mouse)AbsAC40_uM26.00001.240012.460025.2000AID602296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (34)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
proteolysisCaspase-7Homo sapiens (human)
apoptotic processCaspase-7Homo sapiens (human)
heart developmentCaspase-7Homo sapiens (human)
response to UVCaspase-7Homo sapiens (human)
protein processingCaspase-7Homo sapiens (human)
protein catabolic processCaspase-7Homo sapiens (human)
defense response to bacteriumCaspase-7Homo sapiens (human)
fibroblast apoptotic processCaspase-7Homo sapiens (human)
striated muscle cell differentiationCaspase-7Homo sapiens (human)
neuron apoptotic processCaspase-7Homo sapiens (human)
protein maturationCaspase-7Homo sapiens (human)
lymphocyte apoptotic processCaspase-7Homo sapiens (human)
cellular response to lipopolysaccharideCaspase-7Homo sapiens (human)
cellular response to staurosporineCaspase-7Homo sapiens (human)
execution phase of apoptosisCaspase-7Homo sapiens (human)
positive regulation of plasma membrane repairCaspase-7Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-7Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
RNA bindingCaspase-7Homo sapiens (human)
aspartic-type endopeptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-7Homo sapiens (human)
protein bindingCaspase-7Homo sapiens (human)
peptidase activityCaspase-7Homo sapiens (human)
cysteine-type peptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in execution phase of apoptosisCaspase-7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular spaceCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
cytoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
nucleoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (43)

Assay IDTitleYearJournalArticle
AID715803Antiproliferative activity against human U937 cells assessed as incorporation of [3H]-methyl-thymidine after 12 hrs by scintillation counting2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715795Induction of apoptosis in human U937 cells assessed as reduction of normal cells at 500 uM after 24 hrs by Annexin V-FITC double staining2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID1330873Inhibition of human recombinant GST-tagged Atg4B expressed in Escherichia coli at 500 uM using LC3B-GST as substrate after 6 mins by SDS-PAGE assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay.
AID650664Inhibition of human carbonic anhydrase 9 after 6 hrs by stop-flow CO2 hydration assay2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII.
AID776843Cellular uptake in mouse Neuro2a cells at 50 uM after 3 hrs by Alexa Fluor 488-conjugated wheat germ agglutinin/TOTO-3 staining-based laser scanning confocal microscopic analysis2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
Targeting botulinum A cellular toxicity: a prodrug approach.
AID1556837Antiproliferative activity against human WiDr cells assessed as growth inhibition measured after 48 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-01, Volume: 179Selenocoumarins as new multitarget antiproliferative agents: Synthesis, biological evaluation and in silico calculations.
AID624608Specific activity of expressed human recombinant UGT1A42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID715802Cytotoxicity against human U937 cells after 48 hrs by trypan blue assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID1556835Antiproliferative activity against human HeLa cells assessed as growth inhibition measured after 48 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-01, Volume: 179Selenocoumarins as new multitarget antiproliferative agents: Synthesis, biological evaluation and in silico calculations.
AID650662Inhibition of human carbonic anhydrase 1 after 6 hrs by stop-flow CO2 hydration assay2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII.
AID1556836Antiproliferative activity against human T47D cells assessed as growth inhibition measured after 48 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-01, Volume: 179Selenocoumarins as new multitarget antiproliferative agents: Synthesis, biological evaluation and in silico calculations.
AID1776685Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Synthesis and Biological Activity of Triterpene-Coumarin Conjugates.
AID315165Growth inhibition of human U937 cells by [3H]thymidine incorporation assay2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells.
AID1776683Cytotoxicity against mouse B16-F10 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Synthesis and Biological Activity of Triterpene-Coumarin Conjugates.
AID1556833Antiproliferative activity against human A549 cells assessed as growth inhibition measured after 48 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-01, Volume: 179Selenocoumarins as new multitarget antiproliferative agents: Synthesis, biological evaluation and in silico calculations.
AID315164Cytotoxicity against human U937 cells by trypan blue assay after 48 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells.
AID420327Displacement of Atto700-HA from HDAC up to 50 uM by fluorescence anisotropy2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases.
AID715783Induction of cell differentiation in human U937 cells assessed as increase of CD11b and CD14 expression at 500 uM after 72 hrs by FACS flow cytometer analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID1330874Inhibition of human recombinant GST-tagged Atg4B expressed in Escherichia coli assessed as uncleaved substrate level at 500 uM using LC3B-GST as substrate after 6 mins by SDS-PAGE assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay.
AID715793Induction of apoptosis in human U937 cells assessed as activation of caspase-3 at 500 uM after 24 hrs by colorimetric assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID1776684Cytotoxicity against human HT-29 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Synthesis and Biological Activity of Triterpene-Coumarin Conjugates.
AID650665Inhibition of human carbonic anhydrase 12 after 6 hrs by stop-flow CO2 hydration assay2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII.
AID1556834Antiproliferative activity against human HBL100 cells assessed as growth inhibition measured after 48 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-01, Volume: 179Selenocoumarins as new multitarget antiproliferative agents: Synthesis, biological evaluation and in silico calculations.
AID315168Induction of apoptosis in human U937 cells at 250 uM after 24 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells.
AID420328Displacement of Atto700-HA from HDAC at 100 uM by fluorescence anisotropy2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases.
AID593513Binding affinity to corpus collosum myelin in central nervous system of mouse at 100 uM after 20 mins by fluorescent microscopy2011Journal of medicinal chemistry, Apr-14, Volume: 54, Issue:7
Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination.
AID650663Inhibition of human carbonic anhydrase 2 after 6 hrs by stop-flow CO2 hydration assay2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (122)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (10.66)18.7374
1990's18 (14.75)18.2507
2000's39 (31.97)29.6817
2010's43 (35.25)24.3611
2020's9 (7.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.38 (24.57)
Research Supply Index4.82 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index47.76 (26.88)
Search Engine Supply Index2.05 (0.95)

This Compound (34.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.82%)5.53%
Reviews1 (0.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other120 (98.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]